---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-419154"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2026-10-09T20:30:14+00:00"
generated_at: "2026-10-12T15:07:27.958978+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics gets Nasdaq delisting notice over $2.5M equity rule; plans hearing

## Summary
- Nasdaq staff notified Alaunos on Oct. 5, 2026 that its securities are subject to delisting for failing Listing Rule 5550(b)(1), the $2,500,000 minimum stockholders' equity requirement.
- Company first received non-compliance notice on April 9, 2026 and submitted a timely plan to regain compliance; that plan was not accepted.
- Alaunos plans to timely request a hearing before the Nasdaq Hearings Panel, which stays suspension or delisting at least until the hearing and any extension expires.
- Company is working with a financial advisor to evaluate strategic alternatives and potential transactions to regain listing compliance; no assurance any deal will be signed or completed.
- Common stock trades on Nasdaq Capital Market under symbol TCRT; signed by CEO Holger Weis, dated October 9, 2026.

## SEC filing metadata
- accession: 0001193125-26-419154
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2026-10-09T20:30:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312526419154/0001193125-26-419154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312526419154/tcrt-20261005.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-419154
- JSON: https://secwatch.observer/filing/0001193125-26-419154.json
- Plain text: https://secwatch.observer/filing/0001193125-26-419154.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.